After participating in this webinar, the learner will be able to:

Recognize current methodologies and clinical indications for intragraft gene expression testing.
Describe new opportunities afforded by emerging FFPE-based intragraft gene expression technologies.
Understand the available data on the use of donor-derived cell-free DNA for solid organ transplants (kidney, pancreas, liver, heart, lung).
Understand the limitations and future directions of available data on the use of donor-derived cell-free DNA for solid organ transplants.
Explain the use of urine as a surrogate for kidney allograft biopsy.
Discuss strategies to develop and validate robust biomolecular markers of kidney allograft status.
Describe urinary cell biomolecular markers of human kidney allograft status.

Dr. Benjamin Adam MD, FRCPC

Assistant Professor of Pathology, University of Alberta